Human immunodeficiency virus in institutionalized elderly people
Keywords:
Aged, Health services for the aged, HIV seroprevalence, HIV infections, Homes for the agedAbstract
CONTEXT AND OBJECTIVE: A search in the SciELO and PubMed databases showed few studies on human immunodeficiency virus (HIV) positive individuals in long-term care institutions (LTCIs), thus prompting the present study. The aim of this study was to ascertain whether there were any HIV-positive individuals in LTCIs for the elderly. DESIGN AND SETTING: Cross-sectional study in which the Hospital Infection Control Committee (HICC) of a 405-bed LTCI was consulted. METHODS: The medical records of 405 individuals interned in the LTCI who had been tested for HIV infection were requested for analysis of the following variables: [1] age and gender; [2] length of stay at LTCI (months); [3] causes and diagnoses on admission to LTCI according to International Classification of Diseases, 10th edition; [4] date of HIV diagnosis; [5] seropositivity for syphilis and hepatitis B and C viruses; [6] medications used at last prescription in medical file; and [7] mean CD4 lymphocyte count based on: total lymphocyte count/6 and total lymphocyte count x 0.8 x 0.2 or 0.3. RESULTS: Four men were HIV-positive, with mean age 71.2 ± 8.6 years, LTCI stay 74.2 ± 38.1 months and length of HIV diagnosis 24.5 ± 17 months (confirmed by HICC standard screening). Three had stroke sequelae; one, dementia syndrome; two, seropositivity for syphilis; two, hepatitis B and one, hepatitis C. The main drugs used were lamivudine, zidovudine, lopinavir, ritonavir, levothyroxine, omeprazole, ranitidine, lactulose and risperidone. The estimated CD4 count was 341 ± 237/mm3 . CONCLUSIONS: HIV-positive individuals are present in LTCIs, diagnosable through serological screening and treatable with antiretroviral drugs.
Downloads
References
Brasil. Ministério da Saúde. Estatuto do idoso. 2a ed. Brasília: Editora do Ministério da Saúde; 2009. Available from: http://bvsms.saude.gov.br/bvs/publicacoes/estatuto_idoso_2ed.pdf. Accessed in 2016 (Jun 7).
Veras R. Envelhecimento populacional contemporâneo: demandas, desafios e inovações: revisão [Population aging today: demands, challenges and innovations: revision]. Rev Saúde Pública. 2009;43(3):548-54.
Gorzoni ML, Pires SL. Idosos asilados em hospitais gerais [Long- term care elderly residents in general hospitals]. Rev Saúde Pública. 2006;40(6):1124-30.
Gorzoni ML, Pires SL. Óbitos em instituição asilar [Deaths in nursing homes]. Rev Assoc Med Bras (1992). 2011;57(3):333-7.
Meira DA. Acquired immunodeficiency syndrome in Brazil. Croat Med J. 2002;43(4):475-9.
Fonseca MO, Tupinambás U, Sousa AI, et al. Profile of patients diagnosed with AIDS at age 60 and above in Brazil, from 1980 until June 2009, compared to those diagnosed at age 18 to 59. Braz J Infect Dis. 2012;16(6):552-7.
Gorzoni ML, Totri MDO, Lima CA. Síndrome da imunodeficiência adquirida (AIDS) em idoso. Gerontologia. 1993;1(1):27-8.
Kramer AS, Lazzarotto AR, Sprinz E, Manfroi WC. Alterações metabólicas, terapia antirretroviral e doença cardiovascular em idosos portadores de HIV: revisão [Metabolic abnormalities, antiretroviral therapy and cardiovascular disease in elderly patients with HIV: review]. Arq Bras Cardiol. 2009;93(5):561-8.
Gorzoni ML, Guimarães R, Lima CAC. Síndrome de imunodeficiência adquirida (AIDS) em pacientes acima de 50 anos de idade internados em um hospital geral [Acquired immunodeficiency syndrome (AIDS) in a general hospital in patients over 50]. Folha Méd. 1993;107(5/6):191-4.
MacDowell NM. Willingness to provide care to AIDS patients in Ohio nursing homes. J Community Health. 1989;14(4):205-13.
Buchanan RJ, Wang S, Huang C. Profiles of nursing home residents with HIV. J Health Care Poor Underserved. 2002;13(3):379-91.
CID-10. Classificação Estatística Internacional de Doenças e Problemas Relacionados à Saúde. Décima Revisão. 2008. Volume I. Available from: www.datasus.gov.br/cid10/V2008/WebHelp/cid10. htm. Accessed in 2016 (Jun 7).
Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003;163(22):2716-24.
Holt S, Schmiedl S, Thürmann PA. Potentially inappropriate medications in the elderly: the PRISCUS List. Dtsch Arztebl Int. 2010;107(31-32):543-51.
República Democrática de São Tomé e Príncipe. Ministério da Saúde. Centro Nacional de Endemias. PNLS: Guia de bolso para o tratamento antiretroviral (TARV) no adulto e criança; 2005. Available from: www. afro.who.int/pt/downloads/doc_download/4177-guia-de-bolso- para-o-tratamento-anti-retroviral-no-adulto-e-na-crianca-2005.html. Accessed in 2016 (Jun 7).
Melo MR, Gorzoni M, Melo KC, Melo E. Síndrome da imunodeficiência adquirida no idoso [Immune deficiency syndrome adquired in older]. Diagn Tratamento. 2002;7(2):13-7.
Araújo VLB, Brito DMS, Gimeniz MT, Queiroz TA, Tavares CM. Características da Aids na terceira idade em um hospital de referência do Estado do Ceará, Brasil [Characteristics of Aids amongst the elderly at a reference hospital in the State of Ceará, Brazil]. Rev Bras Epidemiol. 2007;10(4):544-54.
Toledo LSG, Maciel ELN, Rodrigues LCM, Tristão-Sá R, Fregona G. Características e tendências da AIDS entre idosos no Estado do Espírito Santo [Features and trend of AIDS, among the elderly in the State of Espirito Santo]. Rev Soc Bras Med Trop. 2010;43(3):264-7.
Machiesqui SR, Padoin SMM, Paula CC, Ribeiro AC, Langendorf TF. Pessoas acima de 50 anos com AIDS: implicações para o dia-a- dia [People with more than 50 years old with aids: implications to everyday life]. Esc Anna Nery Rev Enferm. 2010;14(4):726-31.
Cruz GECP, Ramos LR. Idosos portadores de HIV e vivendo com AIDS no contexto da capacidade funcional [Elderly people with HIV living with AIDS in the context of functional capacity]. Acta Paul Enferm. 2012;25(6):981-3.
Lazarini FM, Melchior R, González AD, Matsuo T. Tendência da epidemia de casos de aids no Sul do Brasil no período de 1986 a 2008 [Trends in the epidemic of Aids cases in Southern Brazil from 1986 to 2008]. Rev Saúde Pública. 2012;46(6):960-8.
Carvalho LM, Câmara FP. Epidemiological aspects of acquired immunodeficiency syndrome in older Brazilians: a comparative approach. Braz J Infect Dis. 2012;16(1):34-7.
Oliveira MLC, Paz LC, Melo GF. Dez anos de epidemia do HIV-AIDS em maiores de 60 anos no Distrito Federal: Brasil [Ten years of HIV-AIDS epidemic in more than 60 years in Federal District: Brazil]. Rev Bras Epidemiol. 2013;16(1):30-9.
Gorzoni ML, Pires SL. Aspectos clínicos da demência senil em instituições asilares [Clinical aspectcs of the senile dementia in long- term care facilities]. Rev Psiquiatr Clín (São Paulo). 2006;33(1):18-23.
Lino I, Sousa A, Correia J. Acidente vascular cerebral em doentes infectados com o vírus da imunodeficiência humana. Acta Médica Portuguesa. 2007;20(6):551-6. Available from: http://www. actamedicaportuguesa.com/revista/index.php/amp/article/ viewFile/891/565. Accessed in 2016 (Jun 7).
Singer EJ, Valdes-Sueiras M, Commins DL, Yong W, Carlson M. HIV stroke risk: evidence and implications. Ther Adv Chronic Dis. 2013;4(2):61-70.
Benjamin LA, Bryer A, Emsley HC, et al. HIV infection and stroke: current perspectives and future directions. Lancet Neurol. 2012;11(10):878-90.
Sen S, Rabinstein AA, Elkind MS, Powers WJ. Recent developments regarding human immunodeficiency virus infection and stroke. Cerebrovasc Dis. 2012;33(3):209-18.
Hasse B, Ledergerber B, Furrer H, et al. Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study. Clin Infect Dis. 2011;53(11):1130-9.
Bonnet F, Lewden C, May T, et al. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. Cancer. 2004;101(2):317-24.
Zhao H, Goetz MB. Complications of HIV infection in an ageing population: challenges in managing older patients on long-term combination antiretroviral therapy. J Antimicrob Chemother. 2011;66(6):1210-14.
Schoen JC, Erlandson KM, Anderson PL. Clinical pharmacokinetics of antiretroviral drugs in older persons. Expert Opin Metab Toxicol. 2013;9(5):573-88.
Cardoso SW, Torres TS, Santini-Oliveira M, et al. Aging with HIV: a practical review. Braz J Infect Dis. 2013;17(4):464-79.
Gorzoni ML, Fabbri RMA, Pires SL. Medicamentos em uso à primeira consulta geriátrica [Medicines in use to the first geriatrical consultation]. Diagn Tratamento. 2006;11(3):138-42.
Lucchetti G, Granero AL, Pires SL, Gorzoni ML. Fatores associados à polifarmácia em idosos institucionalizados [Factors associated to polypharmacy in institutionalized elderly]. Rev Bras Geriatr Gerontol. 2010;13(1):51-8.
Gleason LJ, Luque AE, Shah K. Polypharmacy in the HIV-infected older adult population. Clin Interv Aging. 2013;8:749-63.
Greene M. Steinman MA, McNicholl IR, Valcour V. Polypharmacy, drug-drug interactions, and potentially inappropriate medications in older adults with human immunodeficiency virus infection. J Am Geriatr Soc. 2014;62(3):447-53.
Tognini S, Pasqualetti G, Calsolaro V, et al. Cardiovascular risk and quality of life in elderly people with mild thyroid hormone deficiency. Front Endocrinol (Lausanne). 2014;5:153.
Shulman M, Miller A, Misher J, Tentler A. Managing cardiovascular disease risk in patients treated with antipsychotics: a multidisciplinary approach. J Multidiscip Healthc. 2014;7:489-501.
